GD

Gregory Duke

Senior Director of Research at Sagimet Biosciences

Gregory Duke has worked in the field of biosciences for over 25 years. Gregory began their career in 1994 at Aviron as a Scientist III. In 2002, they joined MedImmune Vaccines as a Principal Scientist. In 2012, they were appointed Senior Director of Research at 3-V Biosciences.

Gregory Duke obtained their Doctor of Philosophy (Ph.D.) in Biochemistry from the University of Wisconsin-Madison in 1989.

Location

Menlo Park, United States

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Sagimet Biosciences

Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways.


Employees

11-50

Links